Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

279
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
279

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: Community series in towards precision medicine for immune-mediated disorders: advances in using big data and artificial intelligence to understand heterogeneity in inflammatory responses, volume III.

Frontiers in immunology·2026
Same author

Artery-Like Smooth Muscle Drives Contractile Function in Dural Venous Sinuses.

bioRxiv : the preprint server for biology·2026
Same author

GPIHBP1 on oligodendrocytes binds lipoprotein lipase within the human brain.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Not all reference samples are equal in single-cell transcriptomics of human kidney tissue.

JCI insight·2026
Same author

Deep profiling of lupus nephritis kidneys reveals dynamic changes in myeloid cells associated with disease progression.

Annals of the rheumatic diseases·2026
Same author

Hypoxia inducible factor network reflects kidney disease progression in diabetes and sodium-glucose co-transporters inhibition.

Signal transduction and targeted therapy·2026

Related Experiment Video

Updated: Feb 27, 2026

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice
05:39

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice

Published on: July 8, 2020

2.2K

Transcriptomic and Proteomic Profiling Provides Insight into Mesangial Cell Function in IgA Nephropathy.

Peidi Liu1, Emelie Lassén1, Viji Nair2

  • 1Department of Physiology, Institute of Neuroscience and Physiology.

Journal of the American Society of Nephrology : JASN
|June 25, 2017
PubMed
Summary

IgA nephropathy (IgAN) involves galactose-deficient IgA (gd-IgA) immune complexes in the kidney. Mesangial cell gene expression changes are key to IgAN development and progression, offering new therapeutic targets.

Keywords:
IgA nephropathymesangial cellstranscriptional profiling

More Related Videos

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

781
Optimizing Isolation and Purification of Murine Glomerular Mesangial Cells
04:46

Optimizing Isolation and Purification of Murine Glomerular Mesangial Cells

Published on: March 7, 2025

1.0K

Related Experiment Videos

Last Updated: Feb 27, 2026

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice
05:39

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice

Published on: July 8, 2020

2.2K
Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

781
Optimizing Isolation and Purification of Murine Glomerular Mesangial Cells
04:46

Optimizing Isolation and Purification of Murine Glomerular Mesangial Cells

Published on: March 7, 2025

1.0K

Area of Science:

  • Nephrology
  • Immunology
  • Genomics

Background:

  • IgA nephropathy (IgAN) is the most common glomerulonephritis globally.
  • Its pathophysiology, involving galactose-deficient IgA (gd-IgA) immune complexes, remains incompletely understood.
  • The role of glomerular mesangial cells in IgAN is under investigation.

Purpose of the Study:

  • To investigate the role of mesangial cells in IgAN pathogenesis using integrated transcriptomic and proteomic profiling.
  • To identify key molecular pathways involved in IgAN development and progression.

Main Methods:

  • Microarray analysis of glomerular gene expression in IgAN patients (n=19) and controls (n=22).
  • Analysis of mesangial cell-specific gene expression patterns.
  • Proteomic analysis of mesangial cells and transcriptomic analysis of glomeruli.
  • Correlation of gene expression with clinical parameters (serum creatinine, eGFR) and Oxford MEST score.

Main Results:

  • Differential expression of mesangial cell-associated genes was significantly higher in IgAN compared to podocyte-associated genes.
  • Gene expression data clearly separated IgAN patients from controls based on mesangial cell markers.
  • Mesangial cell gene expression Z-scores correlated with clinical parameters and segmental glomerulosclerosis.
  • Identified 22 common pathways in mesangial cells induced by gd-IgA, primarily related to inflammation.

Conclusions:

  • Mesangial cell dysfunction plays a critical role in IgAN pathogenesis.
  • gd-IgA induces inflammatory pathways in mesangial cells, contributing to disease progression.
  • Identified genes, proteins, and pathways offer novel insights and potential therapeutic targets for IgAN.